1. Home
  2. QH vs FATE Comparison

QH vs FATE Comparison

Compare QH & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QH
  • FATE
  • Stock Information
  • Founded
  • QH 2012
  • FATE 2007
  • Country
  • QH China
  • FATE United States
  • Employees
  • QH N/A
  • FATE N/A
  • Industry
  • QH Business Services
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • QH Consumer Discretionary
  • FATE Health Care
  • Exchange
  • QH Nasdaq
  • FATE Nasdaq
  • Market Cap
  • QH 134.5M
  • FATE 142.4M
  • IPO Year
  • QH 2020
  • FATE 2013
  • Fundamental
  • Price
  • QH $1.41
  • FATE $1.42
  • Analyst Decision
  • QH
  • FATE Hold
  • Analyst Count
  • QH 0
  • FATE 10
  • Target Price
  • QH N/A
  • FATE $6.75
  • AVG Volume (30 Days)
  • QH 8.0K
  • FATE 2.1M
  • Earning Date
  • QH 04-02-2025
  • FATE 03-04-2025
  • Dividend Yield
  • QH N/A
  • FATE N/A
  • EPS Growth
  • QH N/A
  • FATE N/A
  • EPS
  • QH N/A
  • FATE N/A
  • Revenue
  • QH $493,471,493.00
  • FATE $13,447,000.00
  • Revenue This Year
  • QH N/A
  • FATE N/A
  • Revenue Next Year
  • QH N/A
  • FATE N/A
  • P/E Ratio
  • QH N/A
  • FATE N/A
  • Revenue Growth
  • QH N/A
  • FATE N/A
  • 52 Week Low
  • QH $0.25
  • FATE $1.04
  • 52 Week High
  • QH $2.27
  • FATE $8.83
  • Technical
  • Relative Strength Index (RSI)
  • QH 58.31
  • FATE 48.76
  • Support Level
  • QH $1.25
  • FATE $1.43
  • Resistance Level
  • QH $1.37
  • FATE $1.81
  • Average True Range (ATR)
  • QH 0.07
  • FATE 0.14
  • MACD
  • QH 0.01
  • FATE 0.05
  • Stochastic Oscillator
  • QH 64.00
  • FATE 39.06

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform in China. The company provides tech-enabled, end-to-end operational solutions to consumer service businesses in industries with e-commerce exposure, including food delivery, ride-hailing, housekeeping, bike-sharing, and other services. The company generates revenue predominantly from service fees paid by its industry customers, and to a lesser extent, from rental fees under its car leasing agreements with drivers engaged in the ride-hailing solutions. It derives all of its revenue from the PRC. The company's revenues are categorized into On-demand delivery solutions; Mobility service solutions; Housekeeping solutions and other services. The On-demand delivery solutions generate key revenue for the firm.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: